A synthetic peptide for use as a blocking control in assays to test for specificity of LBP antibody, Alternative Names: LBP control peptide, LBP antibody Blocking Peptide, Anti-LBP Blocking Peptide, Lipopolysaccharide Binding Protein Blocking Peptide, MGC22233 Blocking Peptide
LBP is involved in the acute-phase immunologic response to gram-negative bacterial infections. Gram-negative bacteria contain a glycolipid, lipopolysaccharide (LPS), on their outer cell wall. Together with bactericidal permeability-increasing protein (BPI), the protein binds LPS and interacts with the CD14 receptor, probably playing a role in regulating LPS-dependent monocyte responses.